CEO Ying Huang on CART Cell Therapy for Multiple Myeloma

This title was summarized by AI from the post below.

Our CEO, Ying Huang, recently spoke with New Jersey Monthly Magazine on the impact of our #CART #CellTherapy, developed in partnership with Johnson & Johnson Innovative Medicine, and the promise of #CellTherapies for patients living with #MultipleMyeloma. In this month’s issue, Ying shares insights on how Legend is driving #innovation to make transformative therapies more accessible and how our teams in #NewJersey and around the world are working to change the treatment landscape for people facing #Cancer. Read the full story: https://lnkd.in/ew7ySY8D

  • No alternative text description for this image

Mijn kleinzoon werkt in Gent als operator expert

Liz McNamara RN BSN

Executive Cell Therapy Account Specialist

2w

Great article and thank you, Jacqueline Mroz, for capturing the essence of Legend’s CAR T!

See more comments

To view or add a comment, sign in

Explore content categories